Ardelyx Inc (ARDX)

NASDAQ HEALTHCARE
$5.97 -0.33% RSI 48 Neutral Add Alert

Moving Averages

SMA 200
$5.82
Price near

Company Profile

Ardelyx, Inc., a biopharmaceutical company, develops and sells drugs for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company is headquartered in Fremont, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$1.52B
P/E Ratio
None
EPS
$-0.26
Beta
0.657
Dividend Yield
0.00%
52-Week High
$8.4
52-Week Low
$3.21

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 54.0
VRTX
Vertex Pharmaceuticals Inc
RSI 37.0
CRSP
CRISPR Therapeutics AG
RSI 46.0
MRNA
Moderna Inc
RSI 35.0
VKTX
Viking Therapeutics Inc
RSI 39.0
SRPT
Sarepta Therapeutics Inc
RSI 50.0

Data last updated: April 11, 2026 at 4:00 PM EDT

Track ARDX for free

Get e-mail RSI alerts when Ardelyx Inc enters oversold or overbought territory. Free forever.

Add Alert